Stock listing

NASDAQ:VRXA Veraxa Biotech AG Stock

Follow Veraxa Biotech AG into a list and get an email when it puts out news.

Share price · NASDAQ:VRXA

$0.952 USD +0.002 (+0.2%)

Close on Nov 5, 2026

Past 6 months -92.7% · daily closes, May 4, 2026 – Nov 5, 2026, adjusted for splits
Day range
$0.950 – $1.050 USDNov 5, 2026
Volume
151,699 sharesNov 5, 2026
Market cap
$134.6M USDAt the close on Nov 5, 2026 · price × 141.4M shares outstanding
Traded on an average day
$363,597 USDMedian day 125,950 shares · last 3 months, Aug 5, 2026 – Nov 5, 2026

Daily closes

Last 3 months, Aug 5, 2026 – Nov 5, 2026 · NASDAQ:VRXA · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.952+0.002+0.2%$1.010$1.050$0.950151,699
$0.950-0.040-4.0%$0.990$1.018$0.950103,122
$0.990-0.040-3.9%$1.020$1.055$0.96253,496
$1.030-0.110-9.6%$1.140$1.150$1.030286,810
$1.140+0.010+0.9%$1.180$1.249$1.075259,928
$1.130+0.150+15.3%$0.970$1.210$0.970363,015
$0.980-0.020-2.0%$1.020$1.020$0.97068,905
$1.000+0.020+2.0%$1.000$1.020$0.98095,381
$0.980-0.020-2.0%$1.000$1.030$0.950161,639
$1.000-0.030-2.9%$1.040$1.060$0.990137,900
$1.030-0.030-2.8%$1.080$1.080$1.030171,300
$1.060+0.050+5.0%$1.050$1.130$1.050198,100
$1.010+0.010+1.0%$1.090$1.090$0.990126,400
$1.000-0.110-9.9%$1.100$1.100$1.000119,000
$1.110+0.010+0.9%$1.150$1.150$1.080125,500
$1.100-0.010-0.9%$1.130$1.150$1.060114,500
$1.110-0.090-7.5%$1.200$1.200$1.08061,500
$1.200+0.060+5.3%$1.200$1.350$1.120741,300
$1.140-0.120-9.5%$1.220$1.300$1.130156,100
$1.260+0.170+15.6%$1.080$1.409$1.0701,860,900
$1.090-0.110-9.2%$1.190$1.210$1.090211,900
$1.200+0.120+11.1%$1.160$1.320$1.100749,200
$1.080-0.050-4.4%$1.120$1.147$1.040395,300
$1.1300.0000.0%$1.130$1.160$1.120153,200
$1.130-0.060-5.0%$1.150$1.150$1.105150,200
$1.190-0.060-4.8%$1.250$1.250$1.18064,900
$1.250-0.060-4.6%$1.310$1.310$1.175119,500
$1.310-0.060-4.4%$1.370$1.370$1.30052,800
$1.370-0.040-2.8%$1.430$1.440$1.36048,500
$1.4100.0000.0%$1.430$1.450$1.38255,800
$1.410+0.020+1.4%$1.370$1.440$1.37023,300
$1.390-0.020-1.4%$1.440$1.440$1.38043,400
$1.410-0.010-0.7%$1.420$1.436$1.36059,500
$1.420-0.040-2.7%$1.450$1.520$1.42049,100
$1.460-0.010-0.7%$1.500$1.515$1.45016,400
$1.470-0.040-2.6%$1.500$1.530$1.46048,000
$1.510-0.010-0.7%$1.560$1.590$1.49547,600
$1.520-0.110-6.7%$1.610$1.699$1.50052,300
$1.630-0.020-1.2%$1.630$1.720$1.60064,700
$1.6500.0000.0%$1.680$1.720$1.62088,900
$1.650+0.060+3.8%$1.580$1.682$1.570400,100
$1.590-0.010-0.6%$1.620$1.650$1.560188,500
$1.600-0.160-9.1%$1.810$1.900$1.560468,700
$1.760+0.230+15.0%$1.570$1.970$1.5313,582,300
$1.530+0.150+10.9%$1.380$1.680$1.371560,000
$1.380-0.020-1.4%$1.420$1.435$1.360176,200
$1.400+0.050+3.7%$1.380$1.543$1.270384,800
$1.3500.0000.0%$1.390$1.390$1.320296,300
$1.350-0.090-6.2%$1.430$1.450$1.320313,600
$1.440-0.200-12.2%$1.650$1.685$1.365495,000
$1.640-0.090-5.2%$1.850$1.850$1.570425,400
$1.730-0.050-2.8%$1.780$1.825$1.720145,700
$1.780-0.170-8.7%$1.980$2.000$1.750301,900
$1.950+0.060+3.2%$1.860$2.000$1.85080,200
$1.890+0.030+1.6%$1.880$1.950$1.85037,100
$1.860+0.070+3.9%$1.780$1.880$1.76041,200
$1.790-0.070-3.8%$1.850$1.850$1.760100,800
$1.860-0.010-0.5%$1.870$1.882$1.81047,200
$1.870-0.020-1.1%$1.910$1.930$1.830188,000
$1.8900.0000.0%$1.870$1.950$1.86091,300
$1.8900.0000.0%$1.890$1.960$1.87040,300
$1.890+0.040+2.2%$1.820$1.970$1.82041,079
$1.850-0.140-7.0%$1.970$1.980$1.820127,800
$1.990+0.130+7.0%$1.870$2.000$1.750155,800
$1.860+0.040+2.2%$1.850$1.890$1.81065,300
$1.820+0.020+1.1%$1.810$1.990$1.783100,400
Ticker
NASDAQ:VRXA
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

VERAXA Biotech (NASDAQ: VRXA) Presents First In Vivo Proof-of-Concept Data for BiTAC-ADC Platform at World ADC Congress

Oct 13, 2026

Closed $1.20 (+5.3%) on Oct 13, 2026

VERAXA Biotech Presents in vivo Proof-of-Concept Data for BiTAC®-ADC Technology at World ADC Congress

Oct 13, 2026

Closed $1.20 (+5.3%) on Oct 13, 2026

VERAXA Biotech (NASDAQ: VRXA) Advances FDA-Aligned Methods to Reduce Animal Testing

Oct 7, 2026

Closed $1.20 (+11.1%) on Oct 7, 2026

VERAXA Biotech Provides Overview on Implementation of FDA-Aligned Human-Relevant Models into R&D Strategy

Oct 7, 2026

Closed $1.20 (+11.1%) on Oct 7, 2026

VERAXA Biotech (NASDAQ: VRXA) Advances Oncology Pipeline as Xlife Sciences Reports First-Half Progress

Sep 24, 2026

Closed $1.41 (+1.4%) on Sep 24, 2026

VERAXA Biotech (NASDAQ: VRXA) Builds Oncology Pipeline Around BiTAC Platform, Public-Market Story Enters Next Phase

Sep 22, 2026

Closed $1.41 (-0.7%) on Sep 22, 2026

VERAXA Biotech (NASDAQ: VRXA) Adds Capital Markets Veteran as CFO While Advancing BiTAC Oncology Pipeline

Sep 18, 2026

Closed $1.46 (-0.7%) on Sep 18, 2026

VERAXA Biotech (NASDAQ: VRXA) Building a New Approach to Precision Cancer Therapy

Sep 16, 2026

Closed $1.51 (-0.7%) on Sep 16, 2026

VERAXA Biotech (NASDAQ: VRXA) Appoints Raju Willener as Chief Financial Officer

Sep 8, 2026

Closed $1.60 (-9.1%) on Sep 8, 2026

VERAXA Biotech Appoints Raju Willener as Chief Financial Officer

Sep 4, 2026

Closed $1.76 (+15.0%) on Sep 4, 2026

All Veraxa Biotech AG news

Decks

Veraxa Biotech AG on 6ix

Sector
Health care
Industry
Biotechnology
News releases
42 in the last 12 months · 42 in all · newest Oct 13, 2026 · oldest 2026
Decks
1 deck · latest Apr 23, 2025

Log in to ask 6ix AI your own questions about Veraxa Biotech AG.